Stuart Gunzburg

Chief Tech/Sci/R&D Officer at EVE HEALTH GROUP LIMITED

Net worth: 455 300 $ as of 31/05/2026

Health Technology

Consumer Services

Profile

Stuart Gunzburg is the founder of Nextract Pty Ltd. Dr. Gunzburg is currently Managing Director & Director at Metavone Ltd. Dr. Gunzburg is also Executive Director & Chief Scientific Officer at EVE Health Group Ltd., starting in 2025.
Dr. Gunzburg holds an MBA and a doctorate from The University of Western Australia.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
EVE HEALTH GROUP LIMITED 7.81%	20/03/2026	27,510,581 ( 7.81% )	455 300 $	31/05/2026

Stuart Gunzburg active positions

Companies	Position	Start
EVE HEALTH GROUP LIMITED	Chief Tech/Sci/R&D Officer	12/06/2025
Metavone Ltd. Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers	Chief Executive Officer	-

All active positions of Stuart Gunzburg

Training of Stuart Gunzburg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stuart Gunzburg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
EVE Health Group Ltd. EVE Health Group Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and retails health and wellness food products	Health Technology
The University of Western Australia The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Metavone Ltd. Metavone Ltd. BiotechnologyHealth Technology Discovers and develops therapeutic treatments for dementia and hormone related cancers	Health Technology